Cancer treatment merits a deeper, relentless probe through a proper assessment of the immunological status and genomic ...

Researchers have developed a novel analytical method for tracking disease progression in patients that shows great potential ...

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and SingHealth, Singapore's largest public healthcare cluster, today announced a strategic partnership to enhance healthcare ...

IntroductionFirst identified by Stevens and Johnson in 1922, SJS and TEN are now recognized as disorders with a continuum of severity, from milder ...

Former Rep. Doug Collins offers a reassuring vision, but the VA’s needs and his support for privatization don’t augur well.

Sociologist W.E.B. Du Bois was the psychologist we have never acknowledged. He warned us about double consciousness—psychiatry just called it psychosis.

Q4 2024 Earnings Call Transcript February 18, 2025 NeoGenomics, Inc. beats earnings expectations. Reported EPS is $0.04, ...

South Africa faces a significant public health challenge with a reported 1 739 congenital syphilis cases in 2023, far ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for ...

What’s Going On is a listing of activities taking place throughout the Downriver community. To submit an event, send an email to [email protected]. List the time, date, location, cost ...

In a Phase III trial, 28 percent of newly diagnosed patients with H3 K27M-mutant diffuse glioma responded to treatment with dordaviprone.

Part two of this series sees Ravijyot Saggu explore pharmacological management recommendations from the new joint chronic asthma guidelines.